Test Reta Cagri for $199 Finnrick The most intensive medical obesity therapy in the pipeline is retatrutide. Retatrutide is the "triple G," a glucose dependent insulinotropic polypeptide (GIP), glucagon like peptide 1 (GLP 1), and glucagon receptor agonist. It has demonstrated robust blood Cagrilintide: The Next Gen Peptide for Weight Loss and Satiety Hubmed Retatrutide Research Peptide Triple Agonist PurePeptix Australia